SIS
NVCR icon

Strategic Investment Solutions’s NovoCure NVCR Stock Holding History

Strategic Investment Solutions’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25
Closed -$446 – 657
2025
Q1 		$446 Hold
25
– – ﹤0.01% 576
2024
Q4 		$745 Hold
25
– – ﹤0.01% 576
2024
Q3 		$391 Hold
25
– – ﹤0.01% 580
2024
Q2 		$569 Buy
+25
New +$440 ﹤0.01% 556

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Strategic Investment Solutions's NVCR Position: Q2 2025 in Review

Strategic Investment Solutions sold out of NovoCure (NVCR) in Q2 2025, closing a stake of 25 shares — an estimated $446 sold.

Strategic Investment Solutions first reported a position in NVCR in Q2 2024 and held it in 4 quarters. The position peaked at $745 in Q4 2024. 242 funds tracked by Wall St. Rank hold NVCR as of Q2 2025.

  • Strategic Investment Solutions reported no remaining NovoCure position as of Q2 2025 after selling out during the quarter.
  • Strategic Investment Solutions sold 25 NovoCure shares in Q2 2025, an estimated $446.
  • Strategic Investment Solutions first reported a position in NovoCure in Q2 2024 and held it in 4 quarters.
  • Strategic Investment Solutions's NovoCure position peaked at $745 in Q4 2024.
  • 242 funds tracked by Wall St. Rank held NovoCure as of Q2 2025.

Based on Strategic Investment Solutions's 13F filing for Q2 2025, filed 16 Jul 2025.